Literature DB >> 11040106

Altered expression of proteins of metabolic regulation during remodeling of the left ventricle after myocardial infarction.

A Remondino1, N Rosenblatt-Velin, C Montessuit, I Tardy, I Papageorgiou, P A Dorsaz, M Jorge-Costa, R Lerch.   

Abstract

Non-infarcted myocardium after coronary occlusion undergoes progressive morphological and functional changes. The purpose of this study was to determine whether non-infarcted myocardium exhibits (1) alteration of the substrate pattern of myocardial metabolism and (2) concomitant changes in the expression of regulatory proteins of glucose and fatty acid metabolism. Myocardial infarction was induced in rats by ligation of the left coronary artery. One day and eight weeks after coronary occlusion, glucose and palmitate oxidation were measured. Expression of selected proteins of metabolism were determined one day to 12 weeks after infarction. One day after coronary occlusion no difference of glucose and palmitate oxidation was detectable, whereas after eight weeks, glucose oxidation was increased (+84%, P<0.05) and palmitate oxidation did not change significantly (-19%, P=0.07) in infarct-containing hearts, compared with hearts from sham-operated rats. One day after coronary occlusion, myocardial mRNA expression of the glucose transporter GLUT-1 was increased (+86%, P<0.05) and the expression of GLUT-4 was decreased (-28%, P<0.05) in surviving myocardium of infarct-containing hearts. Protein level of GLUT-1 was increased (+81%, P<0.05) and that of GLUT-4 slightly, but not significantly, decreased (-16%, P=NS). mRNA expressions of heart fatty acid binding protein (H-FABP), and of medium chain acyl-CoA dehydrogenase (MCAD), were decreased by 36% (P<0.05) and 35% (P=0. 07), respectively. Eight weeks after acute infarction, the left ventricle was hypertrophied and, at this time-point, there was no difference in the expression of GLUT-1 and GLUT-4 between infarcted and sham-operated hearts. However, myocardial mRNA and protein content of MCAD were decreased by 30% (P<0.01) and 27% (P<0.05), respectively. In summary, in surviving myocardium, glucose oxidation was increased eight weeks after coronary occlusion. Concomitantly, mRNA and protein expression of MCAD were decreased, compatible with a role of altered expression of regulatory proteins of metabolism in post-infarction modification of myocardial metabolism. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11040106     DOI: 10.1006/jmcc.2000.1234

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  20 in total

1.  Metabolomic analysis of pressure-overloaded and infarcted mouse hearts.

Authors:  Brian E Sansbury; Angelica M DeMartino; Zhengzhi Xie; Alan C Brooks; Robert E Brainard; Lewis J Watson; Andrew P DeFilippis; Timothy D Cummins; Matthew A Harbeson; Kenneth R Brittian; Sumanth D Prabhu; Aruni Bhatnagar; Steven P Jones; Bradford G Hill
Journal:  Circ Heart Fail       Date:  2014-04-24       Impact factor: 8.790

Review 2.  Obesity and Cardiometabolic Defects in Heart Failure Pathology.

Authors:  Ganesh V Halade; Vasundhara Kain
Journal:  Compr Physiol       Date:  2017-09-12       Impact factor: 9.090

Review 3.  Surgical and physiological challenges in the development of left and right heart failure in rat models.

Authors:  Michael G Katz; Anthony S Fargnoli; Sarah M Gubara; Elena Chepurko; Charles R Bridges; Roger J Hajjar
Journal:  Heart Fail Rev       Date:  2019-09       Impact factor: 4.214

4.  The myocardial contractile response to physiological stress improves with high saturated fat feeding in heart failure.

Authors:  Jessica M Berthiaume; Molly S Bray; Tracy A McElfresh; Xiaoqin Chen; Salman Azam; Martin E Young; Brian D Hoit; Margaret P Chandler
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-05-28       Impact factor: 4.733

5.  Longitudinal evaluation of left ventricular substrate metabolism, perfusion, and dysfunction in the spontaneously hypertensive rat model of hypertrophy using small-animal PET/CT imaging.

Authors:  Andrew M Hernandez; Jennifer S Huber; Stephanie T Murphy; Mustafa Janabi; Gengsheng L Zeng; Kathleen M Brennan; James P O'Neil; Youngho Seo; Grant T Gullberg
Journal:  J Nucl Med       Date:  2013-10-03       Impact factor: 10.057

6.  Myocardial energetics in left ventricular hypertrophy.

Authors:  Mohammad N Jameel; Jianyi Zhang
Journal:  Curr Cardiol Rev       Date:  2009-08

Review 7.  Alterations in mitochondrial function in cardiac hypertrophy and heart failure.

Authors:  Moritz Osterholt; T Dung Nguyen; Michael Schwarzer; Torsten Doenst
Journal:  Heart Fail Rev       Date:  2013-09       Impact factor: 4.214

8.  Counter-regulatory effects of incremental hypoxia on the transcription of a cardiac fatty acid oxidation enzyme-encoding gene.

Authors:  Kholiswa C Ngumbela; Michael N Sack; M Faadiel Essop
Journal:  Mol Cell Biochem       Date:  2003-08       Impact factor: 3.396

9.  Myocardial metabolic regulation through peroxisome proliferator-activated receptor alpha after myocardial infarction.

Authors:  Katsuhiko Masamura; Nobuyoshi Tanaka; Masahiro Yoshida; Masayuki Kato; Yasuyuki Kawai; Koji Oida; Isamu Miyamori
Journal:  Exp Clin Cardiol       Date:  2003

10.  Inactivation of peroxisome proliferator-activated receptor isoforms alpha, beta/delta, and gamma mediate distinct facets of hypertrophic transformation of adult cardiac myocytes.

Authors:  Corinne Pellieux; Christophe Montessuit; Irène Papageorgiou; René Lerch
Journal:  Pflugers Arch       Date:  2007-07-21       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.